2'-deoxyadenosine triphosphate has been researched along with Leukemia L 1210 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, GJ; Kimball, AP | 1 |
| Cory, AH; Cory, JG | 1 |
| Balzarini, J; De Clercq, E; Hatse, S; Naesens, L | 1 |
| Kwok, JB; Tattersall, MH | 1 |
4 other study(ies) available for 2'-deoxyadenosine triphosphate and Leukemia L 1210
| Article | Year |
|---|---|
Dipyridamole enhancement of toxicity to L1210 cells by deoxyadenosine and deoxycoformycin combinations in vitro.
Topics: Animals; Antineoplastic Agents; Cell Survival; Chromatography, High Pressure Liquid; Coformycin; Deoxyadenine Nucleotides; Deoxyadenosines; Dipyridamole; Drug Therapy, Combination; Leukemia L1210; Mice; Pentostatin; Ribonucleosides; Ribonucleotide Reductases | 1984 |
Cellular responses in mouse leukemia L1210 cells made resistant to deoxyadenosine.
Topics: Animals; Apoptosis; Aspartic Acid; Deoxyadenine Nucleotides; Deoxyadenosines; Drug Resistance; Guanosine Triphosphate; Isoxazoles; Leukemia L1210; Mice; Nucleotides; Phosphonoacetic Acid; Ribonucleotide Reductases; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1998 |
N6-cyclopropyl-PMEDAP: a novel derivative of 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) with distinct metabolic, antiproliferative, and differentiation-inducing properties.
Topics: Adenine; Adenosine Deaminase; Adenosine Triphosphate; AMP Deaminase; Animals; Antineoplastic Agents; Cell Cycle; Cell Differentiation; Cell Division; Deoxyadenine Nucleotides; Drug Interactions; Drug Screening Assays, Antitumor; Erythrocytes; Guanine; Humans; K562 Cells; Leukemia L1210; Mice; Organophosphonates; Organophosphorus Compounds; Pentostatin; Prodrugs; Rats; Tumor Cells, Cultured | 1999 |
Inhibition of 2-desamino-2-methyl-10-propagyl-5,8-dideazafolic acid cytotoxicity by 5,10-dideazatetrahydrofolate in L1210 cells with decrease in DNA fragmentation and deoxyadenosine triphosphate pools.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Survival; Deoxyadenine Nucleotides; DNA, Neoplasm; Drug Antagonism; Folic Acid; Folic Acid Antagonists; Hypoxanthine; Hypoxanthines; Leukemia L1210; Mice; Tetrahydrofolates; Thymine Nucleotides; Tumor Cells, Cultured | 1991 |